Bajaj Finance, Biocon & more: Top stocks to buy on December 9 — Check list
JP Morgan maintains a neutral stance on Bajaj Finance, citing strategic growth plans and market share ambitions. Goldman Sachs also holds a neutral rating for Biocon, following its planned integration with Biocon Biologics. Kotak Institutional Equities initiates coverage on Tata Capital with an ‘add’ rating, anticipating strong loan growth.🕒 1 min read
JP Morgan maintains a neutral stance on Bajaj Finance, citing strategic growth plans and market share ambitions. Goldman Sachs also holds a neutral rating for Biocon, following its planned integration with Biocon Biologics. Kotak Institutional Equities initiates coverage on Tata Capital with an ‘add’ rating, anticipating strong loan growth.
Continue Reading
- Virat Kohli keeps taking giant strides: Records India’s run-machine set in IND vs NZ ODIs
-
RBI In Talks With Banks To Assess Risks Posed By Anthropic’s Mythos: Report
- American Vlogger Tries Iconic Indian Snacks For The First Time, Watch Her Reaction
-
“Targeting One Party…”: Supreme Court Junks Tamil MP’s Plea, Fines Rs 10 Lakh
- Air India CEO Campbell Wilson Steps Down: Report
- Pet Owner Shoots At Man After Argument Over Dog In UP, Case Filed: Cops
-
Virat Kohli, Rohit Sharma’s Return Series ‘Cancelled’ Over Diplomatic Conflict: Report
-
“Orbiting The Earth. Jai Hind, Jai Bharat”: Shubhanshu Shukla’s Space Message
- Amid US-Iran war, India in talks with Trump administration for Chabahar port sanctions waiver; why it’s important
- New Zealand vs South Africa 3rd T20I Live Score Updates
